Horse anti-SARS-CoV immunogloblin

马抗SARS-CoV免疫球蛋白

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHorse anti-SARS-CoV immunogloblin
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Fab fragment
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusDiscontinued (IND)
Highest Status in ChinaDiscontinued
Originator CompaniesInstitute Of Microbiology And Epidemiology, Chinese Academy Of Military Medical SciencesBeijing Institute Of Biological Products Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Institute Of Biological Products Co LtdInstitute Of Microbiology And Epidemiology, Chinese Academy Of Military Medical Sciences
Active IndicationsN/A
Inactive IndicationsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A